Hypertension in Ghana: a Cross-sectional Community Prevalence Study in Greater Accra
Overview
Social Sciences
Authors
Affiliations
Objectives: To determine the prevalence of hypertension, and the extent to which it is treated and controlled, among adult Ghanaians.
Design: 6300 adults, aged 25 years and older, were selected by random cluster sampling, using electoral enumeration areas and listings of adults.
Setting: Three communities in the greater Accra region of Ghana.
Subjects And Methods: A total of 4733 subjects (male to female ratio = 1:1.5) participated, representing a response rate of 75%. The analysis used the mean of 2 blood pressure readings, taken with a mercury sphygmomanometer after a 10-minute rest. Hypertension was defined as having blood pressure > or = 140/90 mm Hg, or currently undergoing anti-hypertensive treatment.
Results: The mean ages for males and females were 44.9 +/- 14.7 years, and 44.0 +/- 14.6 years, respectively. The crude prevalence of hypertension was 28.3%. The age-standardized prevalence, to the new standard world population, was 28.4%. Mean systolic and diastolic blood pressures increased with age. Of 1337 subjects with hypertension, 34% were aware of their condition, 18% were treated, and 4% were controlled (blood pressure < 140/90 mm Hg).
Conclusion: Hypertension is a major public health problem, and is associated with relatively low levels of awareness, drug treatment, and blood pressure control. Population-based prevention strategies, such as reduction in salt intake and integration of hypertension care into primary care, may prove beneficial; however, the determinants of hypertension remain to be ascertained.
Jalo R, Bamgboye E, Salawu M, Akinyemi J, Uja U, Ogah O BMC Cardiovasc Disord. 2025; 25(1):151.
PMID: 40045189 PMC: 11883994. DOI: 10.1186/s12872-025-04603-0.
Zero malaria: a mirage or reality for populations of sub-Saharan Africa in health transition.
Sarpong E, Acheampong D, Fordjour G, Anyanful A, Aninagyei E, Tuoyire D Malar J. 2022; 21(1):314.
PMID: 36333802 PMC: 9636766. DOI: 10.1186/s12936-022-04340-1.
Ogudu U, Nwaiwu O, Fasipe O Int J Cardiol Cardiovasc Risk Prev. 2022; 14:200144.
PMID: 36097516 PMC: 9463461. DOI: 10.1016/j.ijcrp.2022.200144.
Woode E, Boakye-Gyasi E, Obirikorang Y, Adu E, Obirikorang C, Acheampong E Health Sci Rep. 2022; 5(3):e584.
PMID: 35509411 PMC: 9059218. DOI: 10.1002/hsr2.584.
Gedamu D, Sisay W Vasc Health Risk Manag. 2021; 17:363-370.
PMID: 34188478 PMC: 8232868. DOI: 10.2147/VHRM.S298138.